The Global Aptamers Market is expected to
register a growth of significant CAGR 20.2% during the forecast period
(2018–2023).
Aptamers are oligonucleotides
or peptide molecules that bind to a target lipid, nucleic acid molecules or
proteins. Other factors, such as the use of RNA
aptamers have proven to be of high therapeutic and diagnostic value with recent
FDA approval of the first aptamers drug and additional ones in the clinical
pipelines eventually lead to the growth of Aptamers Market Opportunities. They are generated rapidly and applied in the specific detection,
inhibition, and characterization of proteins. Aptamers are multipurpose and
cost-effective which offer complementary or alternative solutions to the
antibodies. Growth in this market is credited to the improvements in aptamer
development technologies, rising research and development investments for the
development and manufacturing of recombinant products by major players and
rising number of companies investing in this market are some of the key driving
factors responsible for the growth of this market. Increasing use of aptamers
in drug discovery and disease treatment may influence this market positively
over forecast period. Nevertheless, ethical issues in using aptamers, stringent
regulations in use of aptamers and slow in reaching marketplace owing to
regulatory hurdles may hinder the growth of this aptamers market over the
estimated period.
Key
Players:
- Aptamer Sciences
- Aptagen
- Base
Pair Biotechnologies
- Ophthotech
Corporation
- Am
Biotechnologies
- Aptamer
Solutions Ltd
- Aptus
Biotech S.L
- Neoventures
Biotechnology Inc
- Somalogic
- Trilink
Biotechnologies
- Vivonics
- Noxxon
Pharma
Segmentation:
- The Global Aptamers Market has been segmented
on the basis of type, application, technology and end users.
- On the basis of type, the market has been
classified as nucleic acid aptamers and peptide aptamers. The nucleic acid
aptamers have been segmented into DNA-Based Aptamers, RNA-Based Aptamers.
- On the basis of application, the market has
been classified as diagnostics, therapeutics development, research and
development, other applications.
- On the basis of technology, the market has
been classified as Selex, X-aptamer and MARAS technique.
- On the basis of end users, the market has been
classified as academic and government research institutes, biotechnology
and pharmaceutical companies, contract research organizations and other
end users.
Regional
Analysis:
The European market is expected to hold the second
largest market share. The market is expected to witness growth owing to the
rising patient population, changing lifestyle, and growing elderly population.
This is expected to provide favorable backgrounds for the market to grow.
Asia-Pacific is projected to be the fastest growing
region for the global aptamers in 2018. The market is expected to register
positive growth owing to enlarged opportunities in diagnostics and development
of pharmaceuticals which remain untapped in the aptamers market.
The Middle East and Africa accounts for the least
share due to stringent government policies and low per capita income.
Comments
Post a Comment